Login
Research AI
Scans
Tools
Watchlists
Login
Home
Charts
Search
Watchlist
Products

Dr Reddys Laboratories Ltd

DRREDDY
NSE
₹1,242.50+0.77%19 Oct 2026 at 3:58 PM
Reports
Pharma Formulations

Dr Reddys Laboratories Ltd

DRREDDY
NSE
₹1,242.50
+0.77%
19 Oct 2026 at 3:58 PM
SOICxStockScans Reports
Ask AI
Pharma Formulations
Indices
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,03,709Cr
Close
Close Price
₹1,242.50
Industry
Industry
Pharma Formulations
PE
Price To Earnings
32.11
PS
Price To Sales
3.12
Revenue
Revenue
₹33,228Cr
Rev Gr TTM
Revenue Growth TTM
-0.87%
PAT Gr TTM
PAT Growth TTM
-44.57%

Quarterly Results

Upcoming Results on
23 Oct 2026
Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
6,9037,2377,1147,6968,0388,3818,5288,5728,8288,7537,5468,100
Growth YoY
Revenue Growth YoY%
9.06.612.713.916.415.819.911.49.84.4-11.5-5.5
Expenses
ExpensesCr
4,8945,2145,2835,5665,9626,1086,5316,3996,8186,8667,1647,240
Operating Profit
Operating ProfitCr
2,0082,0231,8312,1302,0772,2731,9982,1742,0101,888383860
OPM
OPM%
29.128.025.727.725.827.123.425.422.821.65.110.6
Other Income
Other IncomeCr
319219201193314154528291330271480356
Interest Expense
Interest ExpenseCr
35395960768266839194106126
Depreciation
DepreciationCr
376374368381397471455476505521557537
PBT
PBTCr
1,9171,8291,6051,8831,9171,8742,0051,9051,7451,543200553
Tax
TaxCr
435448295490576470419495408354-22118
PAT
PATCr
1,4821,3811,3101,3921,3421,4041,5871,4101,3371,190221436
Growth YoY
PAT Growth YoY%
33.011.036.4-0.9-9.51.721.11.3-0.4-15.3-86.0-69.1
NPM
NPM%
21.519.118.418.116.716.818.616.415.113.62.95.4
EPS
EPS₹
17.816.615.716.715.117.019.117.016.214.52.65.3
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
6,9037,2377,1147,6968,0388,3818,5288,5728,8288,7537,5468,100
Growth YoY
Revenue Growth YoY%
9.06.612.713.916.415.819.911.49.84.4-11.5-5.5
Expenses
ExpensesCr
4,8945,2145,2835,5665,9626,1086,5316,3996,8186,8667,1647,240
Operating Profit
Operating ProfitCr
2,0082,0231,8312,1302,0772,2731,9982,1742,0101,888383860
OPM
OPM%
29.128.025.727.725.827.123.425.422.821.65.110.6
Other Income
Other IncomeCr
319219201193314154528291330271480356
Interest Expense
Interest ExpenseCr
35395960768266839194106126
Depreciation
DepreciationCr
376374368381397471455476505521557537
PBT
PBTCr
1,9171,8291,6051,8831,9171,8742,0051,9051,7451,543200553
Tax
TaxCr
435448295490576470419495408354-22118
PAT
PATCr
1,4821,3811,3101,3921,3421,4041,5871,4101,3371,190221436
Growth YoY
PAT Growth YoY%
33.011.036.4-0.9-9.51.721.11.3-0.4-15.3-86.0-69.1
NPM
NPM%
21.519.118.418.116.716.818.616.415.113.62.95.4
EPS
EPS₹
17.816.615.716.715.117.019.117.016.214.52.65.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
15,56814,19614,28115,44817,51719,04821,54524,67028,01132,64433,70033,228
Growth
Revenue Growth%
3.6-8.80.68.213.48.713.114.513.516.53.2-0.9
Expenses
ExpensesCr
11,98311,72411,93012,27015,04715,17817,77818,32120,07824,09727,24728,088
Operating Profit
Operating ProfitCr
3,5852,4722,3513,1782,4703,8703,7686,3497,9338,5476,4545,140
OPM
OPM%
23.017.416.520.614.120.317.525.728.326.219.115.5
Other Income
Other IncomeCr
2951721553816773395551,0939091,1191,3721,437
Interest Expense
Interest ExpenseCr
83637989989796143171283374416
Depreciation
DepreciationCr
9391,0271,0771,1351,1631,2291,1651,2501,4701,7042,0592,119
PBT
PBTCr
2,8591,5541,3502,3361,8862,8843,0616,0497,2017,6805,3934,041
Tax
TaxCr
751297438386-1409328791,5411,6231,9541,235858
PAT
PATCr
2,1081,2579121,9502,0261,9522,1834,5075,5785,7254,1583,183
Growth
PAT Growth%
-9.8-40.4-27.4113.73.9-3.711.8106.523.82.6-27.4-44.6
NPM
NPM%
13.58.96.412.611.610.310.118.319.917.512.39.6
EPS
EPS₹
25.015.511.423.524.423.526.354.367.067.950.438.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
15,56814,19614,28115,44817,51719,04821,54524,67028,01132,64433,70033,228
Growth
Revenue Growth%
3.6-8.80.68.213.48.713.114.513.516.53.2-0.9
Expenses
ExpensesCr
11,98311,72411,93012,27015,04715,17817,77818,32120,07824,09727,24728,088
Operating Profit
Operating ProfitCr
3,5852,4722,3513,1782,4703,8703,7686,3497,9338,5476,4545,140
OPM
OPM%
23.017.416.520.614.120.317.525.728.326.219.115.5
Other Income
Other IncomeCr
2951721553816773395551,0939091,1191,3721,437
Interest Expense
Interest ExpenseCr
83637989989796143171283374416
Depreciation
DepreciationCr
9391,0271,0771,1351,1631,2291,1651,2501,4701,7042,0592,119
PBT
PBTCr
2,8591,5541,3502,3361,8862,8843,0616,0497,2017,6805,3934,041
Tax
TaxCr
751297438386-1409328791,5411,6231,9541,235858
PAT
PATCr
2,1081,2579121,9502,0261,9522,1834,5075,5785,7254,1583,183
Growth
PAT Growth%
-9.8-40.4-27.4113.73.9-3.711.8106.523.82.6-27.4-44.6
NPM
NPM%
13.58.96.412.611.610.310.118.319.917.512.39.6
EPS
EPS₹
25.015.511.423.524.423.526.354.367.067.950.438.7

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
8583838383838383838384
Reserves
ReservesCr
12,48512,17912,48913,99415,61617,75519,28923,33028,17133,46637,990
Current Liabilities
Current LiabilitiesCr
6,3478,4206,8945,8977,2148,1049,7668,5729,58813,03416,747
Non Current Liabilities
Non Current LiabilitiesCr
1,4671,1353,0792,5454128717694271,0212,4653,145
Total Liabilities
Total LiabilitiesCr
20,38421,81722,54422,46623,22526,61729,74732,28538,86449,42758,123
Current Assets
Current AssetsCr
11,7949,68410,49811,11012,59914,55017,78220,42624,80525,01830,179
Non Current Assets
Non Current AssetsCr
8,59012,13312,04611,35610,62612,06711,96511,86014,05924,40927,944
Total Assets
Total AssetsCr
20,38421,81722,54422,46623,22526,61729,74732,28538,86449,42758,123
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
8583838383838383838384
Reserves
ReservesCr
12,48512,17912,48913,99415,61617,75519,28923,33028,17133,46637,990
Current Liabilities
Current LiabilitiesCr
6,3478,4206,8945,8977,2148,1049,7668,5729,58813,03416,747
Non Current Liabilities
Non Current LiabilitiesCr
1,4671,1353,0792,5454128717694271,0212,4653,145
Total Liabilities
Total LiabilitiesCr
20,38421,81722,54422,46623,22526,61729,74732,28538,86449,42758,123
Current Assets
Current AssetsCr
11,7949,68410,49811,11012,59914,55017,78220,42624,80525,01830,179
Non Current Assets
Non Current AssetsCr
8,59012,13312,04611,35610,62612,06711,96511,86014,05924,40927,944
Total Assets
Total AssetsCr
20,38421,81722,54422,46623,22526,61729,74732,28538,86449,42758,123

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3,2632,1441,8032,8702,9843,5702,8115,8884,5434,6435,674
Investing Cash Flow
Investing Cash FlowCr
-2,039-1,840-1,488-773-492-2,266-2,639-4,137-4,028-5,808-6,549
Financing Cash Flow
Financing Cash FlowCr
-1,700-369-444-2,133-2,516-30-242-2,686-3761,891829
Net Cash Flow
Net Cash FlowCr
-477-65-129-35-241,275-70-936139726-47
Free Cash Flow
Free Cash FlowCr
2,0659268882,3012,5133,5792,8484,7633,0091,9443,374
CFO To PAT
CFO To PAT%
154.8170.6197.6147.2147.3182.9128.8130.681.581.1136.5
CFO To EBITDA
CFO To EBITDA%
91.086.776.790.3120.892.374.692.757.354.387.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3,2632,1441,8032,8702,9843,5702,8115,8884,5434,6435,674
Investing Cash Flow
Investing Cash FlowCr
-2,039-1,840-1,488-773-492-2,266-2,639-4,137-4,028-5,808-6,549
Financing Cash Flow
Financing Cash FlowCr
-1,700-369-444-2,133-2,516-30-242-2,686-3761,891829
Net Cash Flow
Net Cash FlowCr
-477-65-129-35-241,275-70-936139726-47
Free Cash Flow
Free Cash FlowCr
2,0659268882,3012,5133,5792,8484,7633,0091,9443,374
CFO To PAT
CFO To PAT%
154.8170.6197.6147.2147.3182.9128.8130.681.581.1136.5
CFO To EBITDA
CFO To EBITDA%
91.086.776.790.3120.892.374.692.757.354.387.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
51,77843,63234,55046,06951,79875,09571,65376,9611,02,67995,4661,04,7201,03,709
Price To Earnings
Price To Earnings
24.333.836.523.625.638.532.817.118.416.925.032.1
Price To Sales
Price To Sales
3.33.12.43.03.03.93.33.13.72.93.13.1
Price To Book
Price To Book
4.13.62.83.33.34.23.73.33.62.82.82.7
EV To EBITDA
EV To EBITDA
15.219.516.715.521.619.619.312.113.011.416.920.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
67.265.663.059.558.258.156.260.061.359.955.455.4
OPM
OPM%
23.017.416.520.614.120.317.525.728.326.219.115.5
NPM
NPM%
13.58.96.412.611.610.310.118.319.917.512.39.6
ROCE
ROCE%
18.59.48.113.911.314.313.925.024.420.812.612.6
ROE
ROE%
16.810.37.313.812.910.911.319.319.717.110.910.9
ROA
ROA%
10.35.84.08.78.77.37.314.014.311.67.27.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
51,77843,63234,55046,06951,79875,09571,65376,9611,02,67995,4661,04,7201,03,709
Price To Earnings
Price To Earnings
24.333.836.523.625.638.532.817.118.416.925.032.1
Price To Sales
Price To Sales
3.33.12.43.03.03.93.33.13.72.93.13.1
Price To Book
Price To Book
4.13.62.83.33.34.23.73.33.62.82.82.7
EV To EBITDA
EV To EBITDA
15.219.516.715.521.619.619.312.113.011.416.920.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
67.265.663.059.558.258.156.260.061.359.955.455.4
OPM
OPM%
23.017.416.520.614.120.317.525.728.326.219.115.5
NPM
NPM%
13.58.96.412.611.610.310.118.319.917.512.39.6
ROCE
ROCE%
18.59.48.113.911.314.313.925.024.420.812.612.6
ROE
ROE%
16.810.37.313.812.910.911.319.319.717.110.910.9
ROA
ROA%
10.35.84.08.78.77.37.314.014.311.67.27.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Peer Comparison

TORNTPHARM
ZYDUSLIFE
CIPLA
DRREDDY
AUROPHARMA
MANKIND
LUPIN
Market CapitalizationMkt CapCr1,73,3981,11,1121,06,9701,03,70993,29293,06788,678
Close PriceClose₹4,558.701,113.901,324.101,242.501,621.402,253.201,939.20
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE72.7224.8331.7232.1125.3345.5315.65
Price To SalesPS11.033.893.783.122.676.312.96
RevenueRevenueCr15,72328,59228,32433,22834,93514,73829,967
Revenue Growth TTMRev Gr TTM%32.9%21.1%1.9%-0.9%9.1%14.2%28.2%
PAT Growth TTMPAT Gr TTM%7.7%-3.1%-37.8%-44.6%9.5%8.1%49.1%
TORNTPHARM
ZYDUSLIFE
CIPLA
DRREDDY
AUROPHARMA
MANKIND
LUPIN
Market CapitalizationMkt CapCr1,73,3981,11,1121,06,9701,03,70993,29293,06788,678
Close PriceClose₹4,558.701,113.901,324.101,242.501,621.402,253.201,939.20
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE72.7224.8331.7232.1125.3345.5315.65
Price To SalesPS11.033.893.783.122.676.312.96
RevenueRevenueCr15,72328,59228,32433,22834,93514,73829,967
Revenue Growth TTMRev Gr TTM%32.9%21.1%1.9%-0.9%9.1%14.2%28.2%
PAT Growth TTMPAT Gr TTM%7.7%-3.1%-37.8%-44.6%9.5%8.1%49.1%
Annual Reports
FY2026
PDF
FY2025
PDF
FY2024
PDF
FY2023
PDF
FY2022
PDF
FY2021
PDF
FY2020
PDF
Quarterly Reports
FY2026
Jun 26
ResultPPTTranscriptSummary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
ResultPPTTranscriptSummary
Sep 25
ResultPPTTranscriptSummary
Jun 25
ResultPPTTranscriptSummary
Mar 25
ResultPPTTranscriptSummary
Dec 24
Result
PPT
TranscriptSummary
Sep 24
Result
PPT
TranscriptSummary
Jun 24
Result
PPT
TranscriptSummary
Mar 24
Result
PPT
TranscriptSummary
Dec 23
Result
PPT
TranscriptSummary
Sep 23
Result
PPT
TranscriptSummary
Jun 23
Result
PPT
TranscriptSummary
Mar 23
Result
PPT
TranscriptSummary
Dec 22
Result
PPT
TranscriptSummary
Sep 22
Result
PPT
TranscriptSummary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
ResultPPTTranscriptSummary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Quarterly Reports
Jun 26
ResultPPTTranscriptSummary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
ResultPPTTranscriptSummary
Sep 25
ResultPPTTranscriptSummary
Jun 25
ResultPPTTranscriptSummary
Mar 25
ResultPPTTranscriptSummary
Dec 24
Result
PPT
TranscriptSummary
Sep 24
Result
PPT
TranscriptSummary
Jun 24
Result
PPT
TranscriptSummary
Mar 24
Result
PPT
TranscriptSummary
Dec 23
Result
PPT
TranscriptSummary
Sep 23
Result
PPT
TranscriptSummary
Jun 23
Result
PPT
TranscriptSummary
Mar 23
Result
PPT
TranscriptSummary
Dec 22
Result
PPT
TranscriptSummary
Sep 22
Result
PPT
TranscriptSummary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
ResultPPTTranscriptSummary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies